Annelation of the 1,2,4-Triazine Core to 2,3-Benzodiazepine
DOI:
https://doi.org/10.24959/ophcj.25.327856Keywords:
2,3-benzodiazepine, α-ketoester, 1,2,4-triazine, annelationAbstract
A one-pot, stepwise method for the annelation of the 1,2,4-triazine core to the seven-membered 2,3-benzodiazepine ring via the interaction of the corresponding 2,3-benzodiazepin-1-yl- or 2,3-benzodiazepin-4-ylhydrazines with α-ketoesters has been developed. It has been found that a stepwise formation of an azomethine intermediate followed by solvent replacement and subsequent cyclization enables the desired compounds to be obtained in high yields. Derivatives of a new heterocyclic system of [1,2,4]triazino[3,4-a][2,3]benzodiazepine have been synthesized.
Supporting Agency
- The authors received no specific funding for this work.
Downloads
References
- Knutsen, L. J. S.; Williams, M. Epilepsy. In Comprehensive Medicinal Chemistry II; Elsevier, 2007; pp 279–296. https://doi.org/10.1016/B0-08-045044-X/00171-1.
- Postel-Vinay, S.; Herbschleb, K.; Massard, C.; Woodcock, V.; Soria, J.-C.; Walter, A. O.; Ewerton, F.; Poelman, M.; Benson, N.; Ocker, M.; Wilkinson, G.; Middleton, M. First-in-Human Phase I Study of the Bromodomain and Extraterminal Motif Inhibitor BAY 1238097: Emerging Pharmacokinetic/Pharmacodynamic Relationship and Early Termination Due to Unexpected Toxicity. European Journal of Cancer 2019, 109, 103–110. https://doi.org/10.1016/j.ejca.2018.12.020.
|
|
- Qneibi, M.; Jaradat, N.; Hawash, M.; Olgac, A.; Emwas, N. Ortho versus Meta Chlorophenyl-2,3-Benzodiazepine Analogues: Synthesis, Molecular Modeling, and Biological Activity as AMPAR Antagonists. ACS Omega 2020, 5 (7), 3588–3595. https://doi.org/10.1021/acsomega.9b04000.
|
|
- Johnston, G. A. R. Commentary on Alleviation of Anxiety: The Benzodiazepine Saga by Willy Haefely. In Discoveries in Pharmacology; Elsevier, 2023; pp 197–204. https://doi.org/10.1016/B978-0-323-85519-8.00012-2.
- Solyom, S.; Tarnawa, I. Non-Competitive AMPA Antagonists of 2,3-Benzodiazepine Type. CPD 2002, 8 (10), 913–939. https://doi.org/10.2174/1381612024607081.
|
|
- Horváth, E. J.; Horváth, K.; Hámori, T.; Fekete, M. I. K.; Sólyom, S.; Palkovits, M. Anxiolytic 2,3-Benzodiazepines, Their Specific Binding to the Basal Ganglia. Progress in Neurobiology 2000, 60 (4), 309–342. https://doi.org/10.1016/S0301-0082(99)00020-9.
|
|
- Gitto, R.; Orlando, V.; Quartarone, S.; De Sarro, G.; De Sarro, A.; Russo, E.; Ferreri, G.; Chimirri, A. Synthesis and Evaluation of Pharmacological Properties of Novel Annelated 2,3-Benzodiazepine Derivatives. J. Med. Chem. 2003, 46 (17), 3758–3761. https://doi.org/10.1021/jm030821p.
|
|
- Elger, B.; Huth, A.; Neuhaus, R.; Ottow, E.; Schneider, H.; Seilheimer, B.; Turski, L. Novel α-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionate (AMPA) Receptor Antagonists of 2,3-Benzodiazepine Type: Chemical Synthesis, in Vitro Characterization, and in Vivo Prevention of Acute Neurodegeneration. J. Med. Chem. 2005, 48 (14), 4618–4627. https://doi.org/10.1021/jm0580003.
|
|
- De Sarro, G.; Chimirri, A.; De Sarro, A.; Gitto, R.; Grasso, S.; Giusti, P.; Chapman, A. G. GYKI 52466 and Related 2,3-Benzodiazepines as Anticonvulsant Agents in DBA/2 Mice. European Journal of Pharmacology 1995, 294 (2–3), 411–422. https://doi.org/10.1016/0014-2999(95)00561-7.
|
|
- Kharaneko, O. I.; Popov, V. Yu.; Bogza, S. L. 4-Aryl-1-Hydrazino-5H-2,3-Benzodiazepine and 1-Aryl-4-Hydrazino-5H-2,3-Benzodiazepine in the Synthesis of Condensed [1,2]Diazepines. Chem. Heterocycl. Comp. 2013, 49 (2), 317–324. https://doi.org/10.1007/s10593-013-1249-6.
|
- Khabarov, K. M.; Kharaneko, O. I.; Bogza, S. L. 2,3-Benzodiazepine-1-Thione in the Synthesis of Substituted and Hetero-Annelated 2,3-Benzodiazepines. Chem. Heterocycl. Comp. 2009, 45 (4), 468–474. https://doi.org/10.1007/s10593-009-0280-0.
|
- Sztanke, K.; Pasternak, K.; Rzymowska, J.; Sztanke, M.; Kandefer-Szerszeń, M. Synthesis, Structure Elucidation and Identification of Antitumoural Properties of Novel Fused 1,2,4-Triazine Aryl Derivatives. European Journal of Medicinal Chemistry 2008, 43 (5), 1085–1094. https://doi.org/10.1016/j.ejmech.2007.07.009.
|
|
- Sztanke, M.; Rzymowska, J.; Sztanke, K. Synthesis, Structure Elucidation and Identification of Antiproliferative Activities of a Novel Class of Thiophene Bioisosteres Bearing the Privileged 7,8-Dihydroimidazo[2,1-c][1,2,4]Triazin-4(6H)-One Scaffold. Bioorganic & Medicinal Chemistry 2015, 23 (13), 3448–3456. https://doi.org/10.1016/j.bmc.2015.04.037.
|
|
- Harris, R. K.; Becker, E. D.; Cabral De Menezes, S. M.; Granger, P.; Hoffman, R. E.; Zilm, K. W. Further Conventions for NMR Shielding and Chemical Shifts (IUPAC Recommendations 2008). Pure and Applied Chemistry 2008, 80 (1), 59–84. https://doi.org/10.1351/pac200880010059.
|
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 National University of Pharmacy

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).












